These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
15. Improving Combination Osteoporosis Therapy in a Preclinical Model of Heightened Osteoanabolism. Shao Y; Hernandez-Buquer S; Childress P; Stayrook KR; Alvarez MB; Davis H; Plotkin LI; He Y; Condon KW; Burr DB; Warden SJ; Robling AG; Yang FC; Wek RC; Allen MR; Bidwell JP Endocrinology; 2017 Sep; 158(9):2722-2740. PubMed ID: 28637206 [TBL] [Abstract][Full Text] [Related]
16. Two promoters control the mouse Nmp4/CIZ transcription factor gene. Alvarez M; Shah R; Rhodes SJ; Bidwell JP Gene; 2005 Feb; 347(1):43-54. PubMed ID: 15716059 [TBL] [Abstract][Full Text] [Related]
17. Dexamethasone and retinoic acid differentially regulate growth and differentiation in an immortalised human clonal bone marrow stromal cell line with osteoblastic characteristics. Ogston N; Harrison AJ; Cheung HF; Ashton BA; Hampson G Steroids; 2002 Oct; 67(11):895-906. PubMed ID: 12234625 [TBL] [Abstract][Full Text] [Related]
18. Prostaglandin E2 acts via bone marrow macrophages to block PTH-stimulated osteoblast differentiation in vitro. Choudhary S; Blackwell K; Voznesensky O; Deb Roy A; Pilbeam C Bone; 2013 Sep; 56(1):31-41. PubMed ID: 23639875 [TBL] [Abstract][Full Text] [Related]
19. Conditional Loss of Nmp4 in Mesenchymal Stem Progenitor Cells Enhances PTH-Induced Bone Formation. Atkinson EG; Adaway M; Horan DJ; Korff C; Klunk A; Orr AL; Ratz K; Bellido T; Plotkin LI; Robling AG; Bidwell JP J Bone Miner Res; 2023 Jan; 38(1):70-85. PubMed ID: 36321253 [TBL] [Abstract][Full Text] [Related]
20. Loss of Nmp4 enhances bone gain from sclerostin antibody administration. Korff C; Adaway M; Atkinson EG; Horan DJ; Klunk A; Silva BS; Bellido T; Plotkin LI; Robling AG; Bidwell JP Bone; 2023 Dec; 177():116891. PubMed ID: 37660938 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]